Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat severe asthma.
In a study of over 200 participants with severe asthma, the new treatment was shown to have improved asthma symptoms and lung function, while reducing the need for corticosteroids by up to 70%.
According to Statistics Canada, eight per cent of Canadians aged 12 or older – approximately 2.4 million people – have been diagnosed with asthma. Of that, approximately 25% are considered to be severe cases of asthma.
Current treatments for severe asthma often include high doses of corticosteroids, such as prednisone, to control exacerbations. Reducing the need for corticosteroids with alternative treatments is preferable, since these medications are associated with serious side effects from prolonged use – including multi-organ toxicities and immunosuppression.
Parameswaran Nair, professor of medicine at McMaster and staff respirologist at St. Joseph’s Healthcare Hamilton, along with a team of researchers found that an antibody called dupilumab is effective in treating severe asthma in place of high doses of prednisone.
The results were published in the New England Journal of Medicine, one of the world’s most influential medical publications.
Researchers sought participants who had been using oral corticosteroids (prednisone) to treat severe asthma for at least six months prior to the study. In addition to their standard regimen of corticosteroids, patients received either dupilumab or a placebo during the 24 week trial. The corticosteroid dose was gradually reduced during weeks four to 20, and maintained at a low level for the final four weeks.
“The ability of dupilumab to increase lung function as markedly as it did in this study, even in the face of [corticosteroid] withdrawal, indicates that it appears to be inhibiting key drivers of lung inflammation,” the researchers noted.
Dupilumab works to treat asthma by blocking two specific proteins (called interleukin-4 and interleukin-13) that are associated with inflammation of the airways.
This technique was based on Nair’s previous research, (published in the New England Journal of Medicine in 2009 and in 2017). Those studies found that blocking another protein, interleukin-5, allowed patients with high eosinophil levels in their blood and airways to reduce their corticosteroid dose. Eosinophils are a type of white blood cell involved with the production of interleukins. High eosinophil levels are directly linked to an increased risk of severe asthma.
Unlike the previous studies, dupilumab was shown to be effective regardless of patients’ eosinophil levels. Despite the reduced prednisone dose, patients in this study not only experienced a decrease in asthma exacerbations, but their lung function also improved significantly.
“Ultimately, our goal is to find new treatment pathways that allow us to circumvent the use of corticosteroids,” said Nair.
“Since dupilumab showed a significant improvement on asthma control regardless of eosinophil levels, we may be able to use this treatment for a wider range of patients than we previously thought possible. This might be due to the broad effects on inflammation in asthma of the two proteins that we were able to block with dupilumab. The treatment was not associated with any serious side effects.”
The Latest on: Asthma
via Google News
The Latest on: Asthma
- Milken researchers link traffic pollution to 4 million annual cases of childhood asthma on April 18, 2019 at 12:37 am
Researchers in the Milken Institute School of Public Health published a study last week estimating that traffic-related air pollution causes 4 million cases of childhood asthma worldwide annually. A ... […]
- Improper inhaler use common in children with asthma on April 17, 2019 at 8:00 pm
In the first study to evaluate inhaler technique in children hospitalized for asthma - the group at highest risk for complications and death from asthma - researchers found that nearly half of ... […]
- Critical errors in inhaler technique common in children with asthma on April 17, 2019 at 1:57 pm
In the first study to evaluate inhaler technique in children hospitalized for asthma—the group at highest risk for complications and death from asthma—researchers found that nearly half of ... […]
- Comprehensive Growth of Asthma Treatment Market In-Depth Analysis On Forthcoming Development And Huge Profits by 2025 on April 17, 2019 at 7:47 am
Apr 17, 2019 (Reports Monitor via COMTEX) -- Asthma Treatment market provides a detailed analysis of the industry for the estimation period of 2019 - 2025. Asthma Treatment Market by Reports Monitor ... […]
- Mild equine asthma can distinguish winners from losers on the racetrack on April 17, 2019 at 5:57 am
From chariot racing in ancient Rome to the modern Kentucky Derby, horse racing has been celebrated in some form for more than a thousand years. Whether the horses' hooves were pounding around in a ... […]
- Link found between delivery method and asthma, allergies on April 17, 2019 at 4:50 am
Babies born via cesarean delivery may have an increased risk of developing asthma and food allergies, according to research out of the School of Public Health. The prevalence of children with ... […]
- Large multi-ethnic genome-wide association study of asthma identifies novel associations on April 16, 2019 at 12:33 pm
A large, multi-ethnic genome-wide association study (GWAS) of asthma identified novel associations with potential relevance for asthma susceptibility in older adults of diverse racial backgrounds. ... […]
- Health Matters: Understanding Asthma on April 16, 2019 at 5:35 am
It can present with chest tightness, shortness of breath, even wheezing. “Asthma is one of the leading reasons for emergency department visits for children four and younger,” explained Teresa Summe, ... […]
- Millions of children worldwide develop asthma annually due to traffic-related pollution on April 15, 2019 at 11:47 am
About 4 million children worldwide develop asthma each year because of inhaling nitrogen dioxide air pollution, according to a new study. The study, based on data from 2010 to 2015, estimates that 64 ... […]
via Bing News